UROGEN PHARMA LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.37 USD | +5.82% |
|
-14.64% | +9.27% |
| 06-18 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Ahead of Speeches by Fed Officials | MT |
| 06-14 | Oppenheimer Adjusts UroGen Pharma Price Target to $40 From $32, Maintains Outperform Rating | MT |
